[1]
Godoy, M.R., Boscato, S. e Heineck, I. 2023. Cost Minimization Analysis (CMA) of XELOX versus MFOLFOX6 in the treatment of colorectal cancer in a public hospital in Brazil. JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA. 3, s.1 (jan. 2023). DOI:https://doi.org/10.22563/2525-7323.2018.v3.s1.p.34.